CA2975170C - Oleanoyl peptide composition and collagen enhancement - Google Patents

Oleanoyl peptide composition and collagen enhancement Download PDF

Info

Publication number
CA2975170C
CA2975170C CA2975170A CA2975170A CA2975170C CA 2975170 C CA2975170 C CA 2975170C CA 2975170 A CA2975170 A CA 2975170A CA 2975170 A CA2975170 A CA 2975170A CA 2975170 C CA2975170 C CA 2975170C
Authority
CA
Canada
Prior art keywords
skin
peptide
oleanolic acid
linked
expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2975170A
Other languages
English (en)
French (fr)
Other versions
CA2975170A1 (en
Inventor
Muhammed Majeed
Kalyanam Nagabhushanam
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority claimed from PCT/US2015/067277 external-priority patent/WO2016126343A1/en
Publication of CA2975170A1 publication Critical patent/CA2975170A1/en
Application granted granted Critical
Publication of CA2975170C publication Critical patent/CA2975170C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/542—Carboxylic acids, e.g. a fatty acid or an amino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/04—Preparations for care of the skin for chemically tanning the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/57—Compounds covalently linked to a(n inert) carrier molecule, e.g. conjugates, pro-fragrances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Birds (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Emergency Medicine (AREA)
CA2975170A 2010-12-28 2015-12-22 Oleanoyl peptide composition and collagen enhancement Active CA2975170C (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US12/979,667 US8987212B2 (en) 2007-08-07 2010-12-28 Oleanoyl peptide composition and method of treating skin aging
US14/614,538 US20150148297A1 (en) 2007-08-07 2015-02-05 Oleanoyl peptide composition and collagen enhancement
US14/614,538 2015-02-05
PCT/US2015/067277 WO2016126343A1 (en) 2015-02-05 2015-12-22 Oleanoyl peptide composition and collagen enhancement

Publications (2)

Publication Number Publication Date
CA2975170A1 CA2975170A1 (en) 2016-08-11
CA2975170C true CA2975170C (en) 2020-04-14

Family

ID=45464381

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2975170A Active CA2975170C (en) 2010-12-28 2015-12-22 Oleanoyl peptide composition and collagen enhancement

Country Status (10)

Country Link
US (3) US8987212B2 (enExample)
EP (1) EP2510919A3 (enExample)
JP (3) JP6176893B2 (enExample)
KR (1) KR20170101946A (enExample)
AU (2) AU2011265587B2 (enExample)
BR (1) BRPI1105822A2 (enExample)
CA (1) CA2975170C (enExample)
EA (1) EA035128B9 (enExample)
MY (1) MY188723A (enExample)
WO (1) WO2012091743A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8987212B2 (en) * 2007-08-07 2015-03-24 Muhammed Majeed Oleanoyl peptide composition and method of treating skin aging
WO2016105607A1 (en) 2014-12-23 2016-06-30 Avon Products, Inc. Peptides and their use in the treatment of skin
KR20200115683A (ko) * 2015-02-05 2020-10-07 무하메드 마제에드 올레아노일 펩티드 조성물 및 콜라겐 증진
US9597274B2 (en) 2015-06-17 2017-03-21 Avon Products, Inc. Peptides and their use in the treatment of skin
US10493020B2 (en) 2016-04-14 2019-12-03 The Procter & Gamble Company Method of improving the appearance of periorbital dyschromia
KR102007078B1 (ko) 2017-03-24 2019-08-05 (주)셀아이콘랩 콜라겐 생성을 촉진시키는 신규한 헵타펩타이드 단량체 및 이량체를 포함하는 피부 노화 방지를 위한 화장품 조성물
CN111417384A (zh) 2017-09-14 2020-07-14 菲尼克斯生物技术公司 用于治疗神经系统病况的方法和改进的神经保护性组合物
CA3075729A1 (en) 2017-09-14 2019-03-21 Phoenix Biotechnology, Inc. Use of oleandrin to treatn viral infection
AU2018335280B2 (en) * 2017-09-21 2021-10-28 Sami Labs Limited Process for preparing tripeptide containing oleanolic acid and its therapeutic applications thereof
EA202092219A1 (ru) * 2018-04-03 2021-07-06 Сами Лабс Лимитед Композиции для ухода за кожей и их применение
CN110143994B (zh) * 2019-03-22 2020-08-04 中国医学科学院药用植物研究所 辽东楤木单体皂苷衍生物及其制备方法和用途
CN110117307B (zh) * 2019-03-22 2020-08-04 中国医学科学院药用植物研究所 楤木皂苷衍生物及其制备方法和用途
KR20220151038A (ko) 2020-03-31 2022-11-11 피닉스 바이오테크놀러지 인코포레이티드. 코로나바이러스 감염 예방를 위한 조성물
EP4295854A3 (en) 2020-03-31 2024-04-03 Phoenix Biotechnology, Inc. Method and compositions for treating coronavirus infection
CZ2020207A3 (cs) * 2020-04-09 2021-06-02 Contipro A.S. Pentapeptid odvozený od kaseinu a kompozice, která jej zahrnuje a jejich topické použití

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5055298A (en) 1987-12-01 1991-10-08 Chemisches Laboratorium Dr. Kurt Richter Gmbh Cosmetic composition comprising an extracellular connective tissue matrix
US5198465A (en) 1991-06-19 1993-03-30 Dioguardi Francesco S Compositions based on amino acids for preventing and treating precursor deficiencies in the synthesis of collagen
JP2002515898A (ja) 1997-02-25 2002-05-28 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン ヒトの皮膚での経時老化を防止および治療するための方法および組成物
US6809075B1 (en) 2000-05-30 2004-10-26 Connective Tissue Imagineering Llc Elastin peptide analogs and uses of same incombination with skin enhancing agents
FR2777183B1 (fr) * 1998-04-10 2001-03-02 Oreal Utilisation d'au moins un hydroxystilbene dans une composition destinee a favoriser la desquamation de la peau et composition le comprenant
FR2783169B1 (fr) * 1998-09-15 2001-11-02 Sederma Sa Utilisation cosmetique ou dermopharmaceutique de peptides pour la cicatrisation et pour l'amelioration de l'aspect cutane lors du vieillissement naturel ou accelere (heliodermie, pollution)
US6777389B1 (en) 1998-11-19 2004-08-17 Connective Tissue Imagineering Llc Cosmetic or dermatological use of 7-hydroxylated steroids in combination with elastin derived peptides
US6492326B1 (en) 1999-04-19 2002-12-10 The Procter & Gamble Company Skin care compositions containing combination of skin care actives
WO2001001947A1 (en) * 1999-06-30 2001-01-11 Unilever Plc Cosmetic skin care compositions containing cumic alcohol
US6794362B1 (en) 2000-05-30 2004-09-21 Connective Tissue Imagineering Llc Asparagine containing elastin peptide analogs
FR2813018B1 (fr) * 2000-08-21 2004-02-06 Boots Co Plc Compositions cosmetiques renfermant au moins un compose stimulant la neosynthese des laminines, et/ou de l'integrine alpha-2 beta-1 et/ou du collagene iv de la jonction dermo- epidermique
DE10121069A1 (de) * 2001-04-26 2002-10-31 Beiersdorf Ag Verwendung von Tetrahydrocurcuminoiden oder deren Derivaten als Wirkstoffe zur Herstellung von kosmetischen und dermatologischen Zubereitungen zum Schutz und zur Behandlung der trockenen bzw. alterstrockenen Haut
FR2826266B1 (fr) 2001-06-26 2005-02-25 Oreal Composition cosmetique ou dermatologique comprenant une association entre un compose de la famille des n-acylaminoamides et au moins un inhibiteur de metalloproteinases matricielles
US6906036B2 (en) 2001-08-16 2005-06-14 Kimberly-Clark Worldwide, Inc. Anti-aging and wound healing compounds
US20030124205A1 (en) * 2001-12-28 2003-07-03 Avon Products, Inc. Topical cosmetic composition having a natural plant active ingredient and method of using same
KR100753472B1 (ko) * 2002-03-15 2007-08-31 주식회사 엘지생활건강 사람 콜라겐 ⅰ형의 ｃ-말단에서 유래된 펩타이드에ｔａｔ 펩타이드가 결합된 융합 펩타이드, 이의 제조방법,및 이를 포함하는 피부주름개선 화장료 조성물
US8691247B2 (en) * 2006-12-26 2014-04-08 Ad Lunam Labs Inc. Skin rejuvenation cream
US20090169651A1 (en) * 2007-06-28 2009-07-02 Muhammed Majeed Anti-skin damage compositions with complimentary dual mode of action
US8383594B2 (en) * 2007-08-07 2013-02-26 Sami Labs Limited Peptides modified with triterpenoids and small organic molecules: synthesis and use in cosmeceuticals
US8987212B2 (en) * 2007-08-07 2015-03-24 Muhammed Majeed Oleanoyl peptide composition and method of treating skin aging
US20110294731A1 (en) * 2009-02-13 2011-12-01 Invitrx, Inc. Skin cream

Also Published As

Publication number Publication date
EA201791761A1 (ru) 2017-11-30
US8987212B2 (en) 2015-03-24
AU2011265587A1 (en) 2012-07-12
AU2015381703A1 (en) 2017-07-27
BRPI1105822A2 (pt) 2018-11-21
US20110091398A1 (en) 2011-04-21
JP2017206503A (ja) 2017-11-24
CA2975170A1 (en) 2016-08-11
AU2015381703B2 (en) 2020-02-20
EP2510919A2 (en) 2012-10-17
AU2011265587B2 (en) 2017-01-05
US10071043B2 (en) 2018-09-11
JP2012140428A (ja) 2012-07-26
US20160113853A1 (en) 2016-04-28
EA035128B9 (ru) 2020-08-07
MY188723A (en) 2021-12-25
US20150148297A1 (en) 2015-05-28
EP2510919A3 (en) 2014-08-13
WO2012091743A1 (en) 2012-07-05
JP6176893B2 (ja) 2017-08-09
EA035128B1 (ru) 2020-04-30
JP2018505890A (ja) 2018-03-01
KR20170101946A (ko) 2017-09-06

Similar Documents

Publication Publication Date Title
US10071043B2 (en) Oleanoyl peptide composition and skin hydration
US20140206842A1 (en) Peptides Modified with Triterpenoids and Small Organic Molecules: Synthesis and use in Cosmeceutical
JP4572003B2 (ja) 自然老化または老化亢進性（日光皮膚炎、汚染）の際の、瘢痕化、保湿化および皮膚外観改良用のペプチドの化粧品としてのまたは皮膚薬品としての使用
KR102281774B1 (ko) 피부 재생 및 항염 효과가 있는 피부 상태 개선용 조성물
KR101517950B1 (ko) 철갑상어로부터 수득한 점액을 함유하는 화장료 조성물
JP7426117B2 (ja) 抗皮膚老化剤
US8383594B2 (en) Peptides modified with triterpenoids and small organic molecules: synthesis and use in cosmeceuticals
JP6282582B2 (ja) 皮膚老化の徴候を低減または遅延させるための、ジンゲロンまたはその誘導体の使用
CN114010526A (zh) 一种抗衰多肽组合物及其应用
EP3253400B1 (en) Oleanoyl peptide composition
JP2008100943A (ja) インスリン様成長因子−１分泌促進作用を有する皮膚外用剤
CN116327633A (zh) 一种祛皱抗衰组合物及其制备方法与应用
Baumann et al. Energizing the skin with phytoglycogen
JP7553151B1 (ja) ボトリオコッセンを有効成分として含有する皮膚美容用組成物
KR20160132255A (ko) 천연물 먹인 달팽이 점액의 제조방법 및 이를 함유하는 화장료 조성물
KR102678014B1 (ko) 손상된 무 추출물을 유효성분으로 포함하는 피부 재생 및 노화방지용 화장물 조성물
CN117860607A (zh) 一种协同抗衰的多肽组合物及其应用
KR100692951B1 (ko) 카텝신 비 저해물질을 유효성분으로 함유하는 기능성화장료 조성물
KR20060034471A (ko) 치자추출물을 유효성분으로 함유하는 기능성 화장료 조성물
KR20170026835A (ko) 민챙이 점액을 포함하는 민챙이 추출물을 함유하는 화장료 조성물
KR101460670B1 (ko) 참바늘버섯 자실체 추출물을 함유하는 여드름 개선, 예방 또는 치료용 조성물
WO2019123553A1 (ja) 皮膚に有用な放線菌培養物

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20171003

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-4-4-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20250929

H13 Ip right lapsed

Free format text: ST27 STATUS EVENT CODE: N-4-6-H10-H13-H100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE AND LATE FEE NOT PAID BY DEADLINE OF NOTICE

Effective date: 20260112

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: N-6-6-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20260112

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: N-6-6-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20260203

H13 Ip right lapsed

Free format text: ST27 STATUS EVENT CODE: N-6-6-H10-H13-H100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE AND LATE FEE NOT PAID BY DEADLINE OF NOTICE

Effective date: 20260804